4.6 Article

Circular RNA circMET contributes to tamoxifen resistance of breast cancer cells by targeting miR-204/AHR signaling

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3

Lei Yang et al.

Summary: This study reveals the role of circular RNA CircMET in promoting the development of Xp11.2 translocation/NONO-TFE3 fusion renal cell carcinoma (NONO-TFE3 tRCC). CircMET interacts with specific proteins to regulate mRNA decay of key genes and absorb miRNA, thereby influencing tumor cell proliferation and post-transcriptional regulation.

MOLECULAR CANCER (2022)

Review Biochemistry & Molecular Biology

Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics

Ondrej Slanar et al.

Summary: Personalizing tamoxifen treatment beyond hormone receptor positivity may improve treatment response. Key factors such as CYP2D6 polymorphism, CYP2D6 inhibition, and endoxifen serum levels could be important predictors for treatment personalization in the future. Further research should focus on more precise disease characterization and utilize a multifactorial approach.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)

Review Medical Laboratory Technology

circRNA-miRNA-mRNA in breast cancer

Meilan Zhang et al.

Summary: Breast cancer has the highest incidence rate among women and the circRNA-miRNA-mRNA axis plays a crucial role in its progression, serving as a potential marker for early diagnosis and treatment.

CLINICA CHIMICA ACTA (2021)

Article Oncology

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine

Yuntao Wang et al.

Summary: This study found that Tet can inhibit the growth of tamoxifen-resistant breast cancer cells and enhance the pro-apoptotic effect of tamoxifen by inhibiting autophagy.

INTEGRATIVE CANCER THERAPIES (2021)

Review Biochemistry & Molecular Biology

Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles

Candace M. Day et al.

MOLECULES (2020)

Review Biochemistry & Molecular Biology

Noncoding RNAs in gastric cancer: implications for drug resistance

Ling Wei et al.

MOLECULAR CANCER (2020)

Review Immunology

Breast cancer: Biology, biomarkers, and treatments

Khadijeh Barzaman et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

CircRNA inhibits DNA damage repair by interacting with host gene

Xiaolong Xu et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1

Junjie Xu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Biochemistry & Molecular Biology

The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma

Ling Wei et al.

MOLECULAR CANCER (2019)

Review Medicine, General & Internal

Breast cancer

Nadia Harbeck et al.

LANCET (2017)

Article Oncology

Breast Cancer: Multiple Subtypes within a Tumor?

Syn Kok Yeo et al.

TRENDS IN CANCER (2017)